Literature DB >> 2684226

Ganglioside function in the development and repair of the nervous system. From basic science to clinical application.

S D Skaper1, A Leon, G Toffano.   

Abstract

Gangliosides play important roles in the normal physiological operations of the nervous system, in particular that of the brain. Changes in ganglioside composition occur in the mammalian brain not only during development, but also in aging and in several neuropathological situations. Gangliosides may modulate the ability of the brain to modify its response to cues or signals from the microenvironment. For example, cultured neurons are known to respond to exogenous ganglioside with changes characteristic of cell differentiation. Gangliosides can amplify the responses of neurons to extrinsic protein factors (neuronotrophic factors) that are normal constituents of the neuron's environment. The systemic administration of monosialoganglioside also potentiates trophic actions in vivo and improves neural responses following various types of injury to the adult mammalian central nervous system. The possible molecular mechanism(s) underlying the ganglioside effects may reflect an action in modulating ligand-receptor linked transfer of information across the plasma membrane of the cell.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2684226     DOI: 10.1007/bf02935630

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  154 in total

Review 1.  Glutamate and the pathophysiology of hypoxic--ischemic brain damage.

Authors:  S M Rothman; J W Olney
Journal:  Ann Neurol       Date:  1986-02       Impact factor: 10.422

2.  Impaired axonal transport of acetylcholinesterase in the sciatic nerve of alloxan-diabetic rats: effect of ganglioside treatment.

Authors:  P Marini; M Vitadello; R Bianchi; C Triban; A Gorio
Journal:  Diabetologia       Date:  1986-04       Impact factor: 10.122

3.  Double-blind evaluation of monosialoganglioside (GM1) therapy in stroke.

Authors:  S Bassi; M G Albizzati; M Sbacchi; L Frattola; M Massarotti
Journal:  J Neurosci Res       Date:  1984       Impact factor: 4.164

Review 4.  The plasma membrane as a regulatory site in growth and differentiation of neuroblastoma cells.

Authors:  S W de Laat; P T van der Saag
Journal:  Int Rev Cytol       Date:  1982

5.  GM1 ganglioside as a marker for neuronal differentiation in mouse cerebellum.

Authors:  M Willinger; M Schachner
Journal:  Dev Biol       Date:  1980-01       Impact factor: 3.582

6.  Acceleration of nerve regeneration by gangliosides estimated by the somatosensory evoked potentials (SEP).

Authors:  F Norido; R Canella; F Aporti
Journal:  Experientia       Date:  1981-03-15

7.  Stimulation of neurite outgrowth in vitro by a glycero-ganglioside.

Authors:  M S Cannella; A J Acher; R W Ledeen
Journal:  Int J Dev Neurosci       Date:  1988       Impact factor: 2.457

8.  Gangliosides as bimodal regulators of cell growth.

Authors:  S Spiegel; P H Fishman
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

9.  Antiserum to brain gangliosides produces recurrent epileptiform activity.

Authors:  S E Karpiak; L Graf; M M Rapport
Journal:  Science       Date:  1976-11-12       Impact factor: 47.728

10.  Studies on the cell association of exogenously added sialo-glycolipids.

Authors:  K Radsak; G Schwarzmann; H Wiegandt
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1982-03
View more
  16 in total

1.  Endogenous GM1 ganglioside of the plasma membrane promotes neuritogenesis by two mechanisms.

Authors:  Y Fang; G Wu; X Xie; Z H Lu; R W Ledeen
Journal:  Neurochem Res       Date:  2000-07       Impact factor: 3.996

2.  Uptake of [3H]-gangliosides by an intestinal protozoan, Giardia lamblia.

Authors:  Helen Pope-Delatorre; Siddhartha Das; Louis N Irwin
Journal:  Parasitol Res       Date:  2005-04-06       Impact factor: 2.289

3.  Structural characterization of monosialo-, disialo- and trisialo-gangliosides by negative ion AP-MALDI-QIT-TOF mass spectrometry with MS(n) switching.

Authors:  Emi Ito; Akio Tominaga; Hiroaki Waki; Kozo Miseki; Azusa Tomioka; Kazuki Nakajima; Kazuaki Kakehi; Minoru Suzuki; Naoyuki Taniguchi; Akemi Suzuki
Journal:  Neurochem Res       Date:  2012-03-06       Impact factor: 3.996

4.  Effects of postnatal ganglioside administration and hypoxia-exposure on the dopamine release from striatal slices, the behaviour and the ganglioside pattern of 2-3 months old rats.

Authors:  B Brux; K Ogawa; C Berndt; C Wustmann; H D Fishcer; A Lun; T Abe; J Gross
Journal:  J Neural Transm Gen Sect       Date:  1992

5.  The Therapeutic Role of Gangliosides in Neurological Disorders.

Authors:  J S Schneider
Journal:  CNS Drugs       Date:  1994-03       Impact factor: 5.749

Review 6.  Sphingolipid therapy in myocardial ischemia-reperfusion injury.

Authors:  Susheel Gundewar; David J Lefer
Journal:  Biochim Biophys Acta       Date:  2007-09-06

Review 7.  GM2 ganglioside and pyramidal neuron dendritogenesis.

Authors:  S U Walkley; D A Siegel; K Dobrenis
Journal:  Neurochem Res       Date:  1995-11       Impact factor: 3.996

8.  A novel approach for ganglioside structural analysis based on electrospray multiple-stage mass spectrometry.

Authors:  Alina D Zamfir; Zeljka Vukelic; Andrea Schneider; Eugen Sisu; Nicolae Dinca; Arnd Ingendoh
Journal:  J Biomol Tech       Date:  2007-09

9.  LIGA20, a lyso derivative of ganglioside GM1, given orally after cortical thrombosis reduces infarct size and associated cognition deficit.

Authors:  A Kharlamov; I Zivkovic; A Polo; D M Armstrong; E Costa; A Guidotti
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-05       Impact factor: 11.205

10.  Ganglioside alterations in the central nervous system of rats chronically injected with methylmalonic and propionic acids.

Authors:  V M T Trindade; A M Brusque; J R Raasch; L E Pettenuzzo; H P Rocha; C M D Wannmacher; M Wajne
Journal:  Metab Brain Dis       Date:  2002-06       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.